MGLKX | PGRUX | MGLKX / PGRUX | |
Total Expense Ratio | 1.44 | 1.15 | 125% |
Annual Report Gross Expense Ratio | 1.45 | 1.15 | 126% |
Fund Existence | 11 years | 9 years | - |
Gain YTD | 3.290 | 6.703 | 49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 1.65B | 134% |
Annual Yield % from dividends | 1.86 | 2.25 | 83% |
Returns for 1 year | 1.89 | 7.12 | 27% |
Returns for 3 years | -4.92 | 7.12 | -69% |
Returns for 5 years | 12.12 | 22.21 | 55% |
Returns for 10 years | 17.16 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMYX | 20.05 | 0.16 | +0.80% |
Voya Mid Cap Research Enhanced Index W | |||
OTCNX | 78.78 | 0.47 | +0.60% |
Invesco Discovery Large Cap R | |||
GGFRX | 15.02 | 0.07 | +0.47% |
Nationwide BNY Mellon Dyn US Core R | |||
GCVAX | 24.55 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts A | |||
LHCOX | 18.64 | 0.05 | +0.27% |
Lord Abbett Health Care F3 |